Portfolio

TOP
>
Portfolio
>
Metagen Therapeutics, Inc.

Metagen Therapeutics, Inc.

Developing drug discovery and medical businesses using microbiome science

Establishment and operation of a gut microbiota bank and research and development of a gut microbiota drug discovery program toward social implementation of gut microbiota transplantation.

Utilization of Fecal Microbiota Transplantation (FMT) platform and bioinformatics research todevelop multiple pipeline and exploratory studies for gastrointestinal andimmune system diseases

topics

/

/

/

/

/

/

Overview of investee companies

  • Company name

    Metagen Therapeutics, Inc.

  • Type of business

    Medical(medical devices, drug discovery)

  • Representatives

    Taku Nakahara

  • Establishing a company

    January 2020

  • Investment announcement date

    April 2023

  • Capitalist

    Jun Hayashi

  • HP

    https://www.metagentx.com/
  • Phasing

    Early

Contents

Related news

back